To the Editor Gaps in epilepsy are far more pervasive than the frequently mentioned treatment gap. The data gap is the most pervasive. We just do not know enough. The less we know, the more unconcerned we remain, and the less our efforts, including allocating resources, the more we inadvertently extend the status quo. Data from regions with the least substantial epilepsy care and the highest premature mortality attributable to epilepsy are not available. Data that do emerge are often incomplete and disadvantaged by concerns of less than strict compliance with the rigors of scientific methods. Excess premature mortality has been reported from meta-analyses of limited data from low- and middle-income countries.1
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Singh MB, Bhatia R, Patterson V. Premature Mortality in Epilepsy—A Reminder for the Untreated Millions. JAMA Neurol. 2020;77(4):525. doi:10.1001/jamaneurol.2019.5091
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: